2013 annual financial data
Fate Therapeutics 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,583.21%.
Operating income was -17,675,000 USD and net income was -20,894,000 USD.
Operating cash flow was -15,373,000 USD.
Get free Fate Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 971,000 USD
- Operating income
- -17,675,000 USD
- Net income
- -20,894,000 USD
- Operating cash flow
- -15,373,000 USD